Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Comment by Tommkaton Oct 04, 2018 10:07pm
67 Views
Post# 28749354

RE:Company Reps don't even answer phones

RE:Company Reps don't even answer phones look at the cannabis sector . way worst. 

manipulation is the standard practice by big money. 

luckily we don't fluctuate down past 9.5

time and patience will prevail.

the banks want to manipulate as their professional tactics to scare tom di-ck and harry out of cheap shares.

look forward and have an optimistic view cause this is a company i believe will change my 250k shares into something worth waiting for. 

day trading is a waste of time cause you'll end up missing the boat on the ground breaking day .

hold tight fook the penny pinching suits that try so hard to play the game they call a career.

we see the results and future patents , time will spread the clouds and bring sun on our shares to bring growth on what we believe in as a prosperous investment. 
<< Previous
Bullboard Posts
Next >>